Skip Navigation


Carcinogenesis Advance Access originally published online on July 14, 2008
Carcinogenesis 2008 29(8):1572-1580; doi:10.1093/carcin/bgn164
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
29/8/1572    most recent
bgn164v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Cacev, T.
Right arrow Articles by Kapitanovic, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cacev, T.
Right arrow Articles by Kapitanovic, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression

Tamara Cacev*, Senka Radosevic1, Simun Krizanac2 and Sanja Kapitanovic

Division of Molecular Medicine, Ruder Boskovic Institute, Bijenicka cesta 54, 10000 Zagreb, Croatia
1 PLIVA d.d. Research and Development, Ulica grada Vukovara 49, 10000 Zagreb, Croatia
2 Clinical Hospital Dubrava, Avenija Gojka Suska 6, 10000 Zagreb, Croatia

* To whom correspondence should be addressed. Tel: +385 1 4561 108; Fax: +385 1 4561 010; Email: tcacev{at}irb.hr

Cytokines produced in the tumour microenvironment have an important role in cancer pathogenesis. Altered cytokine expression may result in increased susceptibility to and/or poor prognosis in certain cancers. Therefore, the aim of this study was to investigate the influence of interleukin (IL)-8 and IL-10 on sporadic colon cancer development and progression. In our study, a statistically significant increase in IL-8 messenger RNA (mRNA) expression and decrease in IL-10 mRNA expression in tumour tissue compared with normal mucous tissue was observed (P = 0.003; P = 1.3 x 10–9). No association was found between IL-8 –251 A/T genotypes and IL-8 mRNA expression in tumour and corresponding normal mucous tissue, as well as susceptibility to sporadic colon cancer. Positive immunohistochemical IL-8 staining was more frequent in moderately and poorly differentiated tumours compared with well-differentiated tumours (P = 0.024). Finally, IL-8 significantly stimulated invasion of HT-29 cells in vitro (P = 0.000172). Significant association of IL-10 –1082 A/G, –819 T/C and –592 A/C genotypes and IL-10 mRNA expression in tumour tissue was observed (P = 0.022; P = 0.013; P = 0.02). Significant association of –819 T/C and –592 A/C genotypes and IL-10 mRNA expression in corresponding normal mucous tissue was observed (P = 0.01; P = 0.04) as well. IL-10 single-nucleotide polymorphism (SNP) promoter genotypes associated with low IL-10 mRNA expression (–819 TT; –592 AA) were also associated with increased risk of sporadic colon cancer compared with high-expression genotypes [odds ratio, 5.53; 95% confidence interval (CI), 1.53–20.1; odds ratio, 4.07; 95% CI, 1.28–12.96]. Positive IL-10 immunohistochemical reaction was more frequent in well-differentiated and moderately differentiated tumours compared with poorly differentiated tumours (P = 0.036). In Dukes’ C tumours, positive IL-10 immunohistochemical reaction was less frequent compared with Dukes’ A and B tumours (P = 0.023). Taken together, our results point to possible tumour promoting role of IL-8 and potential protective role of IL-10 in sporadic colon cancer.

Abbreviations: CI, confidence interval; IL, interleukin; mRNA, messenger RNA; PCR, polymerase chain reaction; RT, reverse transcription; SNP, single-nucleotide polymorphism

Received May 20, 2008; revised July 1, 2008; accepted July 7, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
A. J. Schetter, N. H. H. Heegaard, and C. C. Harris
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways
Carcinogenesis, January 1, 2010; 31(1): 37 - 49.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.